Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + XELOX vs XELOX in Stage IIIB/IIIC Gastric Cancer
NCT04351867Phase 3Unknown
- Sponsor
- Li-Ning
- Start
- Sep 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in gastric adenocarcinoma, sponsored by Li-Ning. Status: unknown.
02
Drugs
docetaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT04351867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351867.